Magallanes, Zayd Caleb .

HRN: 26-93-75  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/09/2025
CEFOTAXIME 500MG (VIAL)
04/09/2025
04/15/2025
IVTT
120mg
Q12h
Neonatal Pneumonia; T/c MAS
Waiting Final Action 
04/09/2025
AMPICILLIN 500MG (VIAL)
04/09/2025
04/15/2025
IVTT
120mg
Q12h
Neonatal Pneumonia; T/c MAS
Waiting Final Action 
04/09/2025
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
04/09/2025
04/15/2025
IVTT
30mg Iv As LD Then 15mg MD
Q48h
Neonatal Pneumonia; T/c MAS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: